Zobrazeno 1 - 10
of 21
pro vyhledávání: '"A V Tallerova"'
Autor:
T A Lisitsyna, D Iu Vel'tishchev, A N Gerasimov, O F Seravina, O B Kovalevskaia, A E Zeltyn', A A Novikov, E N Aleksandrova, A V Tallerova, L P Kovalenko, A D Durnev, V N Krasnov, E L Nasonov
Publikováno v:
Терапевтический архив, Vol 85, Iss 5, Pp 8-15 (2013)
AIM: To analyze the rate of clinically significant fatigue and to search for its predictors in patients with rheumatoid arthritis (RA)/MATERIAL AND METHODS: The investigation included 95 patients with a valid RA diagnosis. The majority of the patient
Externí odkaz:
https://doaj.org/article/d9d869b0a8dd4da3a79eb6db4579b0d9
Autor:
A. G. Mezhlumyan, A. V. Tallerova, P. Yu. Povarnina, N. M. Sazonova, A. V. Tarasiuk, T. A. Gudasheva
Publikováno v:
Фармакокинетика и Фармакодинамика, Vol 0, Iss 1, Pp 11-17 (2020)
At the Zakusov Institute of Pharmacology designed and synthesized dimeric dipeptide mimetics of the 1st (GK-6) and 4th (GK-2) nerve growth factor loops, 1st (GSB-214), 2nd (GTS-201) and 4th (GSB -106, GSB-106Ac) brain-derived neurotrophic factor loop
Externí odkaz:
https://doaj.org/article/d4dfcd3deb5448cbb115f2500a9500cc
Publikováno v:
Фармакокинетика и Фармакодинамика, Vol 0, Iss 4, Pp 24-27 (2020)
The present work was to study the GSB-106 effect on the immobility behavior of mice Balb/c in the Porsolt test. GSB-106 was administered sub-chronically and chronically intraperitoneal in dose 1 mg/kg. GSB-106 administration significantly decreased i
Externí odkaz:
https://doaj.org/article/939c43bd5c2443acbb8ec661169269b6
Autor:
Tatiana A. Gudasheva, Anna V. Tallerova, Armen G. Mezhlumyan, Tatyana A. Antipova, Ilya O. Logvinov, Yulia N. Firsova, Polina Y. Povarnina, Sergey B. Seredenin
Publikováno v:
Biomolecules, Vol 11, Iss 2, p 252 (2021)
A mimetic of the BDNF loop 4, bis (N-monosuccinyl-L-seryl-L-lysine) hexamethylenediamide, named GSB-106, was designed and synthesized in our scientific group. The compound activated TrkB, MAPK/ERK, PI3K/AKT, and PLCγ in in vitro experiments. In vivo
Externí odkaz:
https://doaj.org/article/fd6b301f445d496195370eaf3ae8921a
Publikováno v:
Pharmaceutical Chemistry Journal. 55:101-105
Antidepressant activities of the original compounds GSB-106 [bis(N-monosuccinyl-L-seryl-L-lysine) hexamethylenediamide], a mimetic of the fourth loop of brain-derived neurotrophic factor (BDNF); GML-3(N-butyl-N-methyl-1-phenylpyrrolo[1,2-a]pyrazine-3
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9e18bcc17203adef7d819015a7072fe2
https://doi.org/10.1007/s11094-021-02397-x
https://doi.org/10.1007/s11094-021-02397-x
Autor:
A. G. Mezhlumyan, T. A. Antipova, T. A. Gudasheva, Anna V. Tallerova, P. Yu. Povarnina, I. O. Logvinov, S. B. Seredenin
Publikováno v:
Pharmaceutical Chemistry Journal. 54:431-434
The influence of the dimeric dipeptide mimetic of brain-derived neurotrophic factor (BDNF) bis(N-monosuccinyl-L-seryl-L-lysine) hexamethylenediamide (GSB-106, dosage form) during three-day peroral administration at a dose of 0.1 mg/kg on the 1% sucro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8f4095770aee2814011156b2047702d5
https://doi.org/10.1007/s11094-020-02217-8
https://doi.org/10.1007/s11094-020-02217-8
Autor:
I. O. Logvinov, Armen G. Mezhlumyan, Anna V. Tallerova, Polina Povarnina, Tatiana A Gudasheva, T. A. Antipova, Yulia N. Firsova, Sergey B. Seredenin
Publikováno v:
Biomolecules
Biomolecules, Vol 11, Iss 252, p 252 (2021)
Volume 11
Issue 2
Biomolecules, Vol 11, Iss 252, p 252 (2021)
Volume 11
Issue 2
A mimetic of the BDNF loop 4, bis (N-monosuccinyl-L-seryl-L-lysine) hexamethylenediamide, named GSB-106, was designed and synthesized in our scientific group. The compound activated TrkB, MAPK/ERK, PI3K/AKT, and PLCγ in in vitro experiments. In vivo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::69eb52d7a4f0292879db9b4820262a3a
https://pubmed.ncbi.nlm.nih.gov/33578683
https://pubmed.ncbi.nlm.nih.gov/33578683
Autor:
S. B. Seredenin, Anna V. Nadorova, Tatiana A Gudasheva, Tatiana A. Antipova, Sergei V. Nikolaev, L. G. Kolik, Anna V. Tallerova, Yulia N. Firsova, Polina Povarnina, Ksenia N. Koliasnikova
Previously it was shown that neuropeptide cyclo-L-prolylglycine (CPG) is a positive modulator of AMPA receptors, which increases BDNF level in neuronal cell cultures. The spectrum of CPG’s pharmacological effects corresponds to that of BDNF. Dipept
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::86d74448889a8a2f193e70a77efae6b0
https://doi.org/10.5772/intechopen.91192
https://doi.org/10.5772/intechopen.91192
Autor:
S. B. Seredenin, K. V. Alekseev, Anna V. Tallerova, P. Yu. Povarnina, V. V. Bueva, E. V. Blynskaya, T. A. Gudasheva
Publikováno v:
Pharmaceutical Chemistry Journal. 52:397-399
A deficiency of brain-derived neurotrophic factor (BDNF) has now been demonstrated in many studies to play a central role in the pathogenesis of depression. The dimeric dipeptide BDNF-mimetic bis(N-monosuccinyl-L-seryl-L-lysine) hexamethylenediamide
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::77105ccc21a427b7b9bb48d9ee6142d6
https://doi.org/10.1007/s11094-018-1828-z
https://doi.org/10.1007/s11094-018-1828-z
Autor:
Sergey B. Seredenin, S. V. Kruglov, Polina Povarnina, Yulia N. Firsova, Tatiana A Gudasheva, Anna V. Tallerova, Аrmen G. Mezhlumyan, Tatiana A. Antipova
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cdddce9b5913b8d3f4f7365713ccd7cb
https://doi.org/10.5772/intechopen.88244
https://doi.org/10.5772/intechopen.88244